LivPhcD®

 

Category: Nutraceuticals

Exhibitor: TCM BIOTECH INTERNATIONAL CORP.

Booth No: L330

 

Characteristic

 

LivPhcD® is the mycelium of Samsoniella hepiali (Paecilomyces hepiali ) which is fermented using exclusive patented technology by TCM. By analyzing the fermentation liquid at various stages, identify the culture conditions with the highest content of active ingredients (adenosine & polysaccharide).
LivPhcD® is an approved New Dietary Ingredient (NDI) by the U.S. FDA, recognized for its ability to promote health, enhance physical strength, and regulate immunity.
Multinational Patent Certifications
● Pharmaceutical composition for preventing and treating liver fibrosis
● Pharmaceutical composition for preventing and treating nonalcoholic fatty liver disease
● Manufacturing patent
Cientific Evidences
● Lower liver cholesterol, liver TG, liver fibrosis, liver collagen, GOT (AST), GPT (ALT)
● Elevate antioxidant and immune capabilities
LivPhcD® Complex Capsules have obtained 4 certifications of healthy food in Taiwan.
● Reduce GOT, GPT levels
● Improve liver fibrosis
● Improve alcoholic fatty liver
● Improve non-alcoholic fatty liver

 

Other Products

 

• 

  CatCHimera Liver Cancer Recurrence Detection Platform

• 

  DEFEHERE® Absorbable Adhesion Barrier

• 

  Ronkyla® Injection

• 

  ARTZDispo®

• 

  HyLink®

• 

  PLTenus Plus Platelet Concentrate Separator

• 

  PORTAHERE Absorbable Adhesion Barrier

 

 

 

Back